In the significant shortage of organs for transplants among other factors, the lower mortality due to road accidents, the improvement in the treatment of patients and the increase in life expectancy. Added to this is the problem of the rejection rate of organswhich in Spain, in the case of kidney and liver, is 25-20%, and last year in the Region of Murcia was more than 20 livers and 20 kidneys.
This has led to promoting new lines of research, such as the one being developed by the Catholic University of Murcia together with the American biotech High Labsled by the Professor at UCAM Juan Carlos Izpisuaand in which the Hospital Clinic of Barcelona.
Via Cell regeneration, researchers work to restore the functioning of damaged organs in the patient and to rejuvenate those extracted for transplantation. “What we started a few months ago is beginning to become a reality,” says Dr. Izpisua Belmonte, for whom “it is a source of pride that UCAM is part of this reality.”
The first study that has been started aims to rejuvenate organs already removed for subsequent transplantation
The The Catholic University of Murcia has invested more than 200 million euros in research since its foundation, as its president explains, Jose Luis Mendoza, “in order to achieve progress in the field of health; medicine, food or sports; to cure diseases, heal human lives”, projects previously developed with the Salk Institute of Californiaoh now with Altos Labs, and that the UCAM promotes and finances.
Yamanaka, Honoris Causa
for the japanese teacher Shinya Yamanaka, 2012 Nobel Laureate in Physiology and Medicine and Senior Scientific Advisor of Altos Labs, it was “an honor” to accept the appointment proposal as Doctor Honoris Causa from the Catholic University of Murcia that the president of the institution, José Luis Mendoza, made to him personally this Thursday night in Madrid.
Also present at the meeting was Dr. Pedro Guillenextraordinary professor of Sports Traumatology at UCAM and founder of the CEMTRO Clinic; Juan Carlos Izpisua, extraordinary professor of Developmental Biology at this university and director of the Altos Labs Institute of Sciences (USA), and Star NunezVice Chancellor of Research. Dr. Yamanaka won the Nobel Prize for the discovery of cell reprogramming, giving rise to a new branch of Medicine: Regenerative Medicine.
Regarding the application of this research, he said that “from the beginning of basic research to clinical practice, ten to thirty years are needed, and sixteen have passed. Scientists do everything possiblebut we cannot predict when we will be able to bring this technology to everyone.”
“Historic act” at the Royal Academy of Medicine of Spain
This is how he rated the President of the Royal Academy, Eduardo Díaz-Rubiothe event held on Thursday at its headquarters in Madrid, in which the UCAM professor Juan Carlos Izpisua was awarded the Medal of Honor “for his scientific, academic and health work” and the “great and significant support” to this institution; and Shinya Yamanaka, Nobel laureate in Medicine appointed Honorary Academician for his “relevant scientific merits”.
Doctors Pedro Guillén and Arturo Fernández-Cruz (president of the Fundación Fernández-Cruz), read the laudatios.
We would like to give thanks to the author of this short article for this awesome material
The UCAM investigates with Altos Labs to regenerate human organs